Published in Eur Urol on May 25, 2012
Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. Eur Urol (2012) 1.27
Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease. Urol Ann (2015) 0.82
PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT. Curr Sex Health Rep (2015) 0.81
Urologists' Perceptions and Practice Patterns in Peyronie's Disease: A Korean Nationwide Survey Including Patient Satisfaction. Korean J Urol (2014) 0.80
Intralesional collagenase in the treatment of Peyronie's disease. Ther Adv Urol (2014) 0.79
The Efficacy of Medical Treatment of Peyronie's Disease: Potassium Para-Aminobenzoate Monotherapy vs. Combination Therapy with Tamoxifen, L-Carnitine, and Phosphodiesterase Type 5 Inhibitor. World J Mens Health (2016) 0.78
Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study. Sex Med (2016) 0.78
Surgical treatment of Peyronie's disease by modified 16-dot placation in China. Transl Androl Urol (2013) 0.78
The periprostatic venous plexus: an unusual source of fatal pulmonary embolism during corporoplasty. Int J Legal Med (2016) 0.77
Experience in the use of collagenase clostridium histolyticum in the management of Peyronie's disease: current data and future prospects. Ther Adv Urol (2014) 0.77
Peyronie's disease: What's around the bend? Indian J Urol (2016) 0.76
A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease. Int J Impot Res (2016) 0.76
Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction. Transl Androl Urol (2017) 0.75
Nonsurgical treatment options in Peyronie's Disease: 2016 update. Turk J Urol (2016) 0.75
Options for the Medical Treatment of Peyronie's Disease. Rev Urol (2014) 0.75
A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study. Int Braz J Urol (2016) 0.75
Surgical treatment of Peyronie's disease with autologous tunica vaginalis of testis. BMC Urol (2016) 0.75
The Egydio geometrical procedure for managing penile curvature using a single relaxing incision: A single-centre experience with 330 patients. Arab J Urol (2015) 0.75
The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review. World J Mens Health (2016) 0.75
Practical Computerized Solution for Incision and Grafting in Peyronie's Disease. Sex Med (2016) 0.75
The Outcome of Multiple Slit on Plaque with Plication Technique for the Treatment of Peyronie's Disease. World J Mens Health (2016) 0.75
Commentary on the myths of Peyronie's disease. Transl Androl Urol (2012) 0.75
Data vs Dogma in Peyronie's Disease. Int Braz J Urol (2016) 0.75
A critical analysis of the surgical outcomes for the treatment of Peyronie's disease. Arab J Urol (2013) 0.75
Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie's disease. Transl Androl Urol (2017) 0.75
A practical overview of considerations for penile prosthesis placement. Nat Rev Urol (2015) 0.75
Long-term results of combined tunica albuginea plication and penile prosthesis implantation for severe penile curvature and erectile dysfunction. Case Rep Urol (2014) 0.75
Superficial tunica albuginea rupture as initial starting point of Peyronie's disease: a topic for interdisciplinary consideration. Biomed Res Int (2015) 0.75
Re: eau guidelines on penile curvature. J Urol (2012) 0.75
Innovative surgical techniques for managing Peyronie's disease: a video presentation. Transl Androl Urol (2013) 0.75
A pilot study of penile hemodynamics in men with penile curvatures. Int J Impot Res (2017) 0.75
Tunical plication in the management of penile curvature due La Peyronie's disease. Our experience on 47 cases. BMC Surg (2012) 0.75
Penile Plication With or Without Degloving of the Penis Results in Similar Outcomes. Sex Med (2017) 0.75
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol (2013) 7.48
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol (2010) 7.20
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol (2013) 6.54
EAU guidelines on prostate cancer. Eur Urol (2007) 6.30
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol (2013) 4.89
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol (2013) 4.65
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol (2013) 4.58
2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98
EAU guidelines on penile cancer: 2014 update. Eur Urol (2014) 3.86
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol (2003) 3.23
European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol (2013) 2.93
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J (2006) 2.91
Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study. Eur Urol (2008) 2.74
Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med (2011) 2.63
Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series. Int J Radiat Oncol Biol Phys (2011) 2.55
A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol (2013) 2.52
Development and validation of a premature ejaculation diagnostic tool. Eur Urol (2007) 2.42
Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol (2011) 2.41
European Association of Urology guidelines on priapism. Eur Urol (2013) 2.41
Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int (2012) 2.31
Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol (2011) 2.29
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial. Eur Urol (2007) 2.24
Long-term results of small intestinal submucosa graft in bulbar urethral reconstruction. Urology (2012) 2.21
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics (2003) 2.17
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Eur Urol (2007) 2.16
Guidelines on Testicular Cancer: 2015 Update. Eur Urol (2015) 2.11
Ejaculation elicited by microstimulation of lumbar spinothalamic neurons. Eur Urol (2008) 2.10
Peyronie's disease and autoimmunity—a real-life clinical study and comprehensive review. J Sex Med (2015) 2.08
EAU guidelines on surgical treatment of urinary incontinence. Eur Urol (2012) 2.05
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin (2004) 2.03
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol (2006) 2.02
Involvement of connexins 43 and 45 in functional mechanism of human detrusor overactivity in neurogenic bladder. Urology (2013) 2.01
Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol (2003) 1.99
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy. BJU Int (2011) 1.99
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int (2013) 1.99
EAU guidelines on chronic pelvic pain. Eur Urol (2009) 1.97
Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol (2006) 1.96
EAU guidelines on testicular cancer: 2011 update. Eur Urol (2011) 1.96
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med (2008) 1.95
Prediction of functional outcomes after nerve-sparing radical prostatectomy: results of conditional survival analyses. Eur Urol (2012) 1.93
Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol (2011) 1.91
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care (2011) 1.91
When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool. Eur Urol (2009) 1.90
EAU guidelines on prostate cancer. Eur Urol (2005) 1.88
Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol (2009) 1.85
Treatment strategy for "non-responders" to tadalafil and vardenafil: a real-life study. Eur Urol (2006) 1.84
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology (2007) 1.83
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur Urol (2006) 1.82
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2004) 1.78
EAU guidelines on vesicoureteral reflux in children. Eur Urol (2012) 1.76
Engaging men with penile cancer in qualitative research: reflections from an interview-based study. Nurse Res (2014) 1.72
Early detection of prostate cancer: European Association of Urology recommendation. Eur Urol (2013) 1.71
EAU guidelines on urological trauma. Eur Urol (2005) 1.70
A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol (2013) 1.70
The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer. J Urol (2012) 1.68
[EAU guidelines on prostate cancer]. Actas Urol Esp (2009) 1.68
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol (2007) 1.65
Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int (2010) 1.65
Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. Urology (2013) 1.62
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. Eur Urol (2007) 1.62
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Eur Urol (2009) 1.62
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. BJU Int (2010) 1.60
Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Eur Urol (2011) 1.58
Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy. Int J Urol (2012) 1.56
The natural history of Peyronie's disease: an ultrasonography-based study. Eur Urol (2007) 1.54
EAU Guidelines on erectile dysfunction: an update. Eur Urol (2006) 1.53
The natural progression and regression of erectile dysfunction: follow-up results from the MMAS and MALES studies. J Sex Med (2011) 1.52
When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy? Int J Urol (2010) 1.52
What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy? J Sex Med (2011) 1.50
How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications. BJU Int (2010) 1.48
Can phosphodiesterase type 5 inhibitors cure erectile dysfunction? Eur Urol (2006) 1.48
Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck. J Sex Med (2012) 1.48
Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol (2011) 1.48
EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol (2004) 1.47
Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment. Urology (2009) 1.46
EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol (2001) 1.46
The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol (2013) 1.45
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. Eur Urol (2007) 1.45
Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int (2014) 1.45
Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha. Eur Urol (2009) 1.45
Diagnostic tests for male erectile dysfunction revisited. Committee Consensus Report of the International Consultation in Sexual Medicine. J Sex Med (2010) 1.44
Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol (2008) 1.44
Dynamics of male sexual arousal: distinct components of brain activation revealed by fMRI. Neuroimage (2005) 1.44